Share of Alkermes (NASDAQ: ALKS) are down 9.6% at 3 p.m. EDT, having been down as much as 15.7%, after the drugmaker released disappointing first-quarter earnings.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,